Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
802,65 B | 23,56% | 6/6 | 34,75% | 19,63% | 40,47% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
576,24 B | 5,27% | 5/5 | 6,91% | -31,78% | 2,41% | UP |
|
Merck NYSE:MRK |
294,04 B | 7,67% | 6/6 | -21,36% | -9,57% | 10,99% | UP |
|
Pfizer NYSE:PFE |
156,83 B | 7,82% | 4/6 | -5,31% | 21,90% | -2,07% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
121,34 B | 1,77% | 5/6 | -0,30% | -0,63% | 7,69% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
115,27 B | 13,44% | 6/6 | 6,43% | -0,47% | 22,98% | UP |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
77,66 B | 9,26% | 5/6 | 5,41% | 6,02% | 15,63% | UP |
|
Zoetis NYSE:ZTS |
49,23 B | 9,80% | 6/6 | 7,18% | 49,14% | 24,32% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
23,34 B | 15,13% | 5/6 | 2,36% | -31,29% | 14,08% | UP |
|
Viatris NasdaqGS:VTRS |
15,39 B | -3,69% | 4/6 | 2,81% | -37,09% | 27,15% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,90 B | 0,00% | 2/4 | 0,00% | 0,00% | 23,76% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,82 B | -1,08% | 1/6 | 4,92% | -37,33% | 41,78% | UP |
|
Balchem NasdaqGS:BCPC |
5,33 B | 8,75% | 6/6 | 8,46% | 4,39% | 21,70% | DOWN |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,78 B | 28,91% | 5/6 | 11,94% | -12,49% | 18,57% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,72 B | 63,45% | 3/5 | 33,54% | 93,39% | 43,84% | DOWN |
|
Corcept Therapeutics NasdaqCM:CORT |
4,10 B | 10,36% | 5/6 | 124,19% | 20,30% | 55,72% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,06 B | 7,83% | 5/6 | 3,41% | -55,16% | 18,56% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,93 B | 2,48% | 3/6 | 8,34% | -23,57% | 27,95% | UP |
|
Endo OTCPK:NDOI |
1,80 B | 3,65% | 0/5 | 61,08% | 23,81% | -100,00% | DOWN |
